Pilot study of targeting magnetic carbon nanotubes to lymph nodes

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Alexiou C, Schmid RJ, Jurgons R et al.: Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur. Biophys. J.35(5),446–450 (2006).
  Medline CASGoogle Scholar
• 2  Chen J, Wang L, Yao Q et al.: Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer. Breast Cancer Res.6(4),R474–R477 (2006).
  CASGoogle Scholar
• 3  Hagiwara A, Takahashi T, Sawai K et al.: Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer – a pilot study. Anticancer Drugs8(7),666–670 (1997).
  Medline CASGoogle Scholar
• 4  Huang Y, Hagiwara A, Wang W et al.: Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer. Anticancer Drugs13(4),431–435 (2002).
  Medline CASGoogle Scholar
• 5  Akamo Y, Mizuno I, Yotsuyanagi T et al.: Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric carcinoma. Jpn J. Cancer Res.85(6),652–658 (1994).
  Medline CASGoogle Scholar
• 6  Kin S, Nakase Y, Fukuda K et al.: Endoscopic local injection of anticancer drugs bound to carbon particles for treatment of advanced rectal cancer, when surgical treatment was contraindicated. Gan To Kagaku Ryoho29(12),2413–2415 (2002).
  MedlineGoogle Scholar
• 7  Ikehara Y, Kojima N: Development of a novel oligomannose-coated liposome-based anticancer drug-delivery system for intraperitoneal cancer. Curr. Opin. Mol. Ther.9(1),53–61 (2007).
  Medline CASGoogle Scholar
• 8  Oussoren C, Storm G: Liposomes to target the lymphatics by subcutaneous administration. Adv. Drug Deliv. Rev.50(1–2),143–156 (2001).
  Medline CASGoogle Scholar
• 9  Phillips WT, Klipper R, Goins B: Novel method of greatly enhanced delivery of liposomes to lymph nodes. J. Pharmacol. Exp. Ther.295(1),309–313 (2000).
  Medline CASGoogle Scholar
• 10  Bianco A, Kostarelos K, Partidos CD et al.: Biomedical applications of functionalised carbon nanotubes. Chem. Commun. (Camb).5,571–577 (2005).
  MedlineGoogle Scholar
• 11  Pantarotto D, Partidos CD, Hoebeke J et al.: Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem. Biol.10(10),961–966 (2003).
  Medline CASGoogle Scholar
• 12  Ajima K, Yudasaka M, Murakami T et al.: Carbon nanohorns as anticancer drug carriers. Mol. Pharm.2(6),475–480 (2005).
  Medline CASGoogle Scholar
• 13  Hampel S, Kunze D, Haase D et al.: Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. Nanomed.3(2),175–182 (2008).▪ First report that demonstrates the possibility of opening and additional filling of carbon nanotubes.
  CASGoogle Scholar
• 14  Ali-Boucetta H, Al-Jamal KT, McCarthy D et al.: Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem. Commun. (Camb).4,459–461 (2008).
  Google Scholar
• 15  Korneva G, Ye H, Gogotsi Y et al.: Carbon nanotubes loaded with magnetic particles. Nano Lett.5(5),879–884 (2005).
  Medline CASGoogle Scholar
• 16  Yang D, Hu JH, Wang CC: Synthesis and characterization of pH-responsive single-walled carbon nanotubes with a large number of carboxy groups. Carbon44(15),3161–3167 (2006).
  CASGoogle Scholar
• 17  Zhang XL, Yang D, Xu P et al.: Characterizing the surface properties of carbon nanotubes by inverse gas chromatography. J. Mater. Sci.42(17),7069–7075 (2007).
  CASGoogle Scholar
• 18  Qu S, Wang J, Kong J et al.: Magnetic loading of carbon nanotube/nano-Fe₃O₄ composite for electrochemical sensing. Talanta71(3),1096–1102 (2007).
  Medline CASGoogle Scholar
• 19  Yang F, Fu DL, Long J et al.: Magnetic lymphatic targeting drug delivery system using carbon nanotubes. Med. Hypotheses70(4),765–767 (2008).
  Medline CASGoogle Scholar
• 20  Harrell MI, Iritani BM, Ruddell A: Lymph node mapping in the mouse. J. Immunol. Methods332(1–2),170–174 (2008).
  Medline CASGoogle Scholar
• 21  Yokota T, Saito T, Narushima Y et al.: Lymph-node staining with activated carbon CH₄0: a new method for axillary lymph-node dissection in breast cancer. Can. J. Surg.43(3),191–196 (2000).
  Medline CASGoogle Scholar
• 22  Murakami T, Sawada H, Tamura G et al.: Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy. Nanomed.3(4),453–463 (2008).▪ Reports that oxidized single-walled carbon nanohorns can migrate, in part, selectively to the adjacent axillary lymph node by intratumor injection.
  CASGoogle Scholar
• 23  Yang ST, Wang X, Jia G et al.: Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol. Lett.181(3),182–189 (2008).
  Medline CASGoogle Scholar
• 24  Schipper ML, Nakayama-Ratchford N, Davis CR et al.: A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol.3(4),216–221 (2008).
  Medline CASGoogle Scholar
• 25  Lacerda L, Ali-Boucetta H, Herrero MA et al.: Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. Nanomed.3(2),149–161 (2008).
  CASGoogle Scholar
• 26  Kitamura K, Hagiwara A, Otsuji E et al.: Activated carbon-oriented gastrectomy for early gastric cancer. Br. J. Surg.82(5),647–650 (1995).
  Medline CASGoogle Scholar
• 27  Imanishi T, Hagiwara A, Sawai K et al.: Visualising lymph nodes by aclarubicin bound to activated carbon particles in breast cancer surgery. Gan To Kagaku Ryoho24(12),1796–1798 (1997).
  Medline CASGoogle Scholar
• 28  Choi JH, Nguyen FT, Barone PW et al.: Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett.7(4),861–867 (2007).
  Medline CASGoogle Scholar
• 29  Takahashi T, Hagiwara A, Shimotsuma M et al.: Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J. Surg.19(4),565–569 (1995).
  Medline CASGoogle Scholar
• 30  Nakase Y, Hagiwara A, Kin S et al.: Intratumoral administration of methotrexate bound to activated carbon particles: antitumor effectiveness against human colon carcinoma xenografts and acute toxicity in mice. J. Pharmacol. Exp. Ther.311(1),382–387 (2004).
  MedlineGoogle Scholar
• 31  Kitamura K, Hagiwara A, Sasabe T et al.: Significant clinical response of activated carbon adsorbed-peplomycin against esophageal cancer: a pilot study. J. Surg. Oncol.52(1),56–60 (1993).
  Medline CASGoogle Scholar
• 32  Liu Z, Chen K, Davis C et al.: Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res.68(16),6652–6660 (2008).▪ First report demonstrating that carbon nanotubes can be used as drug-delivery vehicles to achieve in vivo cancer treatment efficacy in animal models.
  Medline CASGoogle Scholar
• 33  Chen J, Chen S, Zhao X, Kuznetsova LV, Wong SS, Ojima I: Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J. Am. Chem. Soc. DOI: 10.1021/ja805570f (2008) (Epub ahead of print).
  Google Scholar
• 34  Liu Z, Sun XM, Nakayama N et al.: Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano1(1),50–56 (2007).
  MedlineGoogle Scholar
• 35  Liu Z, Davis C, Cai W et al.: Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl Acad. Sci. USA105(5),1410–1415 (2008).▪ Demonstrates that Raman spectroscopy can be used to detect carbon nanotubes in animals.
  Medline CASGoogle Scholar
• 36  Longmire M, Choyke PL, Kobayashi H: Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomed.3(5),703–717 (2008).
  CASGoogle Scholar
• 37  Jain TK, Reddy MK, Morales MA et al.: Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol. Pharm.5(2),316–327 (2008).
  Medline CASGoogle Scholar
• 38  Bottini M, Bruckner S, Nika K et al.: Multiwalled carbon nanotubes induce T lymphocyte apoptosis. Toxicol. Lett.160(2),121–126 (2006).
  Medline CASGoogle Scholar
• 39  Rudge SR, Kurtz TL, Vessely CR et al.: Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy. Biomaterials21(14),1411–1420 (2000).
  Medline CASGoogle Scholar
• 40  Widder KJ, Senyel AE, Scarpelli GD: Magnetic microspheres: a model system of site specific drug delivery in vivo. Proc. Soc. Exp. Biol. Med.158(2),141–146 (1978).
  Medline CASGoogle Scholar
• 41  Alexiou C, Arnold W, Klein RJ et al.: Locoregional cancer treatment with magnetic drug targeting. Cancer Res.60(23),6641–6648 (2000).
  Medline CASGoogle Scholar
• 42  Fortin JP, Wilhelm C, Servais J et al.: Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc.129(9),2628–2635 (2007).
  Medline CASGoogle Scholar
• 43  Ajima K, Murakami T, Mizoguchi Y et al.: Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns. ACS Nano2(10),2057–2064 (2008).
  Medline CASGoogle Scholar
• 44  McCarthy JR, Kelly KA, Sun EY et al.: Targeted delivery of multifunctional magnetic nanoparticles. Nanomed.2(2),153–167 (2007).
  CASGoogle Scholar